Liwei Dong
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 10
-
- NF-κB Signaling Pathways 3
- Co-authors
- Hongyang Wang (42 shared papers)Yexiong Tan (42 shared papers)Yufei Pan (28 shared papers)Tianyi Jiang (27 shared papers)Wen Wen (3 shared papers)Depeng Wang (1 shared paper)Yushan Miao (1 shared paper)Wenqing Le (1 shared paper)
- Journals
- Hepatology (6 papers)Cancer Letters (5 papers)Cell Death and Disease (4 papers)Cell Research (4 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Liwei Dong
99 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 269
- Hepatology 160
- Infectious Diseases 326
- Immunology 182
- Molecular Biology 508
Countries citing papers authored by Liwei Dong
This map shows the geographic impact of Liwei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Dong more than expected).
Fields of papers citing papers by Liwei Dong
This network shows the impact of papers produced by Liwei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Dong. The network helps show where Liwei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 629 | |
| 2 | 2016 | 133 | |
| 3 | 2015 | 126 | |
| 4 | 2007 | 116 | |
| 5 | 2014 | 116 | |
| 6 | 2013 | 80 | |
| 7 | 2015 | 78 | |
| 8 | 2011 | 68 | |
| 9 | 2023 | 68 | |
| 10 | 2022 | 67 | |
| 11 | 2009 | 66 | |
| 12 | 2011 | 66 | |
| 13 | 2013 | 64 | |
| 14 | 2023 | 61 | |
| 15 | 2011 | 59 | |
| 16 | 2016 | 55 | |
| 17 | 2024 | 54 | |
| 18 | 2015 | 53 | |
| 19 | 2007 | 52 | |
| 20 | 2011 | 52 |
About Liwei Dong
Liwei Dong is a scholar working on Hepatology, Cancer Research, Surgery, Gastroenterology and Immunology, having authored 100 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Nanoplatforms for cancer theranostics (6 papers), Gastrointestinal motility and disorders (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), NF-κB Signaling Pathways (3 papers), Ovarian function and disorders (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (269 citations), Hepatology (160 citations), Infectious Diseases (326 citations), Immunology (182 citations) and Molecular Biology (508 citations). Liwei Dong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongyang Wang, Yexiong Tan, Yufei Pan, Tianyi Jiang, Wen Wen, Depeng Wang, Yushan Miao, Wenqing Le, Lihui Xie and Wenru Su. Their work appears in journals such as Hepatology, Cancer Letters, Cell Death and Disease, Cell Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.